Imidex Hires Wes Bolsen as CEO to Commercialize FDA-Cleared Artificial Intelligence Device for Lung Nodule and Mass Detection, Indicative of Potential Early-Stage Lung Cancer Imidex Hires Wes Bolsen as CEO to Commercialize FDA-Cleared Artificial Intelligence Device for Lung Nodule and Mass Detection

IMIDEX Announces FDA 510(k) Clearance for VisiRad™ XR, an AI-powered medical device to help radiologists detect lung nodules in chest X-rays DENVER, Aug. 17, 2023 (GLOBE NEWSWIRE) -- IMIDEX, a leader in developing AI-based solutions to address lung cancer, announces that it has received FDA 510(k) clearance for its flagship VisiRad XR...